The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
| 2 | H05 | Calcium homeostasis | |
| 3 | H05B | Anti-parathyroid agents | |
| 4 | H05BX | Other anti-parathyroid agents | |
| 5 | H05BX04 |
| Active Ingredient | Description | |
|---|---|---|
| Etelcalcetide |
Etelcalcetide is a synthetic peptide calcimimetic agent which reduces PTH secretion through binding and activation of the calcium-sensing receptor. Etelcalcetide is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| PARSABIV Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
